XML 17 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 13,398,036 $ 7,507,659
Short-term investments available-for-sale, at fair value   4,304,901
Accounts receivable 1,550,868 1,377,441
Inventory, net of allowance of $207,880 at June 30, 2017 and $270,307 at December 31, 2016 1,313,507 1,511,053
Prepaid expenses and other 468,431 433,328
Total current assets 16,730,842 15,134,382
Deferred offering costs   49,630
Property and equipment, net 2,880,487 3,270,197
Total assets 19,611,329 18,454,209
Current liabilities:    
Accounts payable 1,343,912 761,663
Accrued liabilities 1,213,611 1,670,286
Deferred revenue - current 637,929 335,659
NuvoGen obligation - current 509,618 604,751
Term loan payable - current 6,668,789 6,389,782
Other current liabilities 224,875 258,850
Total current liabilities 10,598,734 10,020,991
Term loan payable - non-current, net of discount and debt issuance costs 2,214,820 5,389,137
NuvoGen obligation - non-current, net of discount 7,811,866 8,017,356
Other non-current liabilities 533,806 619,587
Total liabilities 21,159,226 24,047,071
Commitments and Contingencies
Stockholders’ deficit:    
Common stock, $0.001 par value; 200,000,000 shares authorized at June 30, 2017 and December 31, 2016; 11,358,324 shares issued and outstanding, at June 30, 2017; 7,939,967 and 7,938,571 shares issued and outstanding, respectively, at December 31, 2016 11,357 7,938
Additional paid-in-capital 125,703,966 110,081,334
Treasury stock, no shares as of June 30, 2017 and 1,396 shares as of December 31, 2016   (75,000)
Accumulated other comprehensive loss   (1,090)
Accumulated deficit (127,263,220) (115,606,044)
Total stockholders’ deficit (1,547,897) (5,592,862)
Total liabilities and stockholders' deficit $ 19,611,329 $ 18,454,209